Revelation Biosciences, Inc. (REVB)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 11:22
Revelation Biosciences Price to Book Value : 0.3921 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.3921 |
| September 04, 2026 | 0.3921 |
| September 03, 2026 | 0.3921 |
| September 02, 2026 | 0.3882 |
| September 01, 2026 | 0.383 |
| August 31, 2026 | 0.3882 |
| August 28, 2026 | 0.4077 |
| August 27, 2026 | 0.3999 |
| August 26, 2026 | 0.3708 |
| August 25, 2026 | 0.3882 |
| August 24, 2026 | 0.4271 |
| August 21, 2026 | 0.4232 |
| August 20, 2026 | 0.4154 |
| August 19, 2026 | 0.4309 |
| August 18, 2026 | 0.4309 |
| August 17, 2026 | 0.4465 |
| August 14, 2026 | 0.4073 |
| August 13, 2026 | 0.4309 |
| August 12, 2026 | 0.4309 |
| August 11, 2026 | 0.4387 |
| August 10, 2026 | 0.4387 |
| August 07, 2026 | 0.4426 |
| August 06, 2026 | 0.4348 |
| August 05, 2026 | 0.4465 |
| August 04, 2026 | 0.4387 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.396 |
| July 31, 2026 | 0.3688 |
| July 30, 2026 | 0.3864 |
| July 29, 2026 | 0.3745 |
| July 28, 2026 | 0.403 |
| July 27, 2026 | 0.4115 |
| July 24, 2026 | 0.4115 |
| July 23, 2026 | 0.4154 |
| July 22, 2026 | 0.4465 |
| July 21, 2026 | 0.4465 |
| July 20, 2026 | 0.4504 |
| July 17, 2026 | 0.4581 |
| July 16, 2026 | 0.4387 |
| July 15, 2026 | 0.4232 |
| July 14, 2026 | 0.4038 |
| July 13, 2026 | 0.3832 |
| July 10, 2026 | 0.3882 |
| July 09, 2026 | 0.3785 |
| July 08, 2026 | 0.3759 |
| July 07, 2026 | 0.3844 |
| July 06, 2026 | 0.396 |
| July 02, 2026 | 0.4193 |
| July 01, 2026 | 0.4038 |
| June 30, 2026 | 0.3999 |
| June 29, 2026 | 0.3129 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | 0.5806 |
| ACADIA Pharmaceuticals, Inc. | 3.672 |
| Agenus, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 25.30 |
| Amgen, Inc. | 18.18 |
Price to Book Value Related Metrics
| Price | 1.01 |
| Earnings Yield | -1.22K% |
| Market Cap | 3.948M |